Pantoprazole
پنتوپرازول
🍽️ Alimentary Tract And MetabolismProton pump inhibitor
Market / country: 🇺🇸 USA
Protonix (US)
🧮 Dose calculator
Erosive esophagitis (GERD) · Regimen source: FDA Protonix · 2.1, Table 1FDA Protonix · 8.4
- • Do not split, chew or crush. FDA Protonix · 2.2
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to any component or substituted benzimidazoles; rilpivirine-containing products. FDA Protonix · 4
Formulations
- 20 mg delayed-release tablet — tablet 🇺🇸 USA FDA Protonix · 3
- 40 mg delayed-release tablet — tablet 🇺🇸 USA FDA Protonix · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Protonix · 8.1
“Risk Summary Available data from published observational studies did not demonstrate an association of major malformations or other adverse pregnancy outcomes with pantoprazole.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Protonix · 8.2
“Risk Summary Pantoprazole has been detected in breast milk of a nursing mother after a single 40 mg oral dose of pantoprazole.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Protonix · 8.4
“The safety and effectiveness of PROTONIX for short-term treatment (up to eight weeks) of EE associated with GERD have been established in pediatric patients 1 year through 16 years of age.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Protonix · 8.5
“In short-term US clinical trials, EE healing rates in the 107 elderly patients (≥65 years old) treated with PROTONIX were similar to those found in patients under the age of 65.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA020987
- DailyMed (FDA label)FDA Protonix
- MedlinePlus (NIH)PantoprazolePantoprazole Injection
- WHO ATC/DDDA02BC02
- Darooyab (Iran)Pantoprazole
🇮🇷 Registered in Iran Darooyab · G-2625/Pantoprazole
Dosage forms with Iranian generic codes, per Darooyab.
- 16673 · PANTOPRAZOLE 15MG CAP · کپسول پنتوپرازول ۱۵ میلیگرم
- 10031 · PANTOPRAZOLE 20MG CAP · کپسول پنتوپرازول ۲۰ میلیگرم
- 02332 · PANTOPRAZOLE 20MG TAB · قرص پنتوپرازول ۲۰ میلیگرم
- 10029 · PANTOPRAZOLE 40MG CAP · کپسول پنتوپرازول ۴۰ میلیگرم
- 02336 · PANTOPRAZOLE 40MG FOR INFUSION · محلول انفوزیون پنتوپرازول ۴۰ میلیگرم
- 02333 · PANTOPRAZOLE 40MG TAB · قرص پنتوپرازول ۴۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Protonix · 3FDA Protonix · 2.1, Table 1FDA Protonix · 8.4FDA Protonix · 2.2FDA Protonix · 4FDA Protonix · 8.1FDA Protonix · 8.2FDA Protonix · 8.5FDA Protonix · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-2625/Pantoprazole
- Clinical review⚠ Unverified